Skip to main content
Log in

Changes of endogenous prostacyclin-level in different experimental gastroduodenal ulcer models of rat

  • Immunosuppression and Inflammation
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

It seems that the gastric antral mucosa either in normal, physiological circumstances, or in IND or STR induced gastric ulcer models, contains significantly more endogenous PG-I2 than that of gastric fundic, mucosa, while the duodenal mucosa contains significantly lower endogenous PG-I2-level compared to the gastric antral or fundic level.

Either in gastric or in duodenal ulceration, the endogenous PG-I2 level basically decreased proportionally to the degree of ulceration—therefore it is tempting to speculate that the endogenous PG-I2 is most probably one of thenatural protective substances in the gastrointestinal mucosa.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. A.K. Hall, H.R. Behrman, Prostaglandins, Biosynthesis, Metabolism, and Mechanism of Cellular Action. InProstaglandins, pp. 1–38 (Ed.J.B. Lee). Elsevier, New York, P.377, (1982).

    Google Scholar 

  2. G.A. Balint andV. Varró,Actinomycin Inhibits Gastric Mucosal Protection by Prostacyclin in Rats, Prostaglandins21, 255–258 (1981).

    PubMed  Google Scholar 

  3. G.A. Balint andV. Varró,Cytoprotective Effect of Prostacyclin and Protein Synthesis, Acta Physiol. Hung.61, 115–122 (1983).

    PubMed  Google Scholar 

  4. J. Náfrádi, G.A. Balint andV. Varró,The Effect of Different Prostaglandins on Cysteamine-induced Duodenal Ulcer in the Rat, Acta Physiol. Hung.64, 339–341 (1984).

    PubMed  Google Scholar 

  5. G.A. Balint, Gizella Karácsony andV. Varró,The Effect of Long-term Prostacyclin Treatment on the Protein, DNA and RNA Content of Rat Gastric Fundic Mucosa, Agents and Actions16, 404–406 (1985).

    PubMed  Google Scholar 

  6. L. Myatt, M. Jagee, P.J. Lewis andM.G. Elder, Metabolism of Prostacyclin and 6-oxo-PG-F in Man. In:Clinical Pharmacology of Prostacyclin, pp. 25–35 (Eds.P.J. Lewis andJ. O'Grady). Raven Press, New York, P.258, (1981).

    Google Scholar 

  7. K. Gréen, M. Hamberg, B. Samuelsson andJ.C. Frölich, Extraction and Chromatographic Procedures for Purification of Prostaglandins, Thromboxanes, Prostacyclin and Their Metabolites. In:Advances in Prostaglandin and Thromboxane Research, vol. 5, Methods in Prostaglandin Research, pp. 1–38 (Ed.J.C. Frölich). Raven Press, New York, P.246, (1978).

    Google Scholar 

  8. O.H. Lowry, N.J. Rosebrough, A.L. Farr andR.J. Randall,Protein Measurement with the Folin Phenol Reagent, J. biol. Chem.193, 265–275 (1951).

    PubMed  Google Scholar 

  9. Th. Gheorghiu (Ed.),Experimental Ulcer. G. Witzstrock, Baden Baden, P.384, (1975).

    Google Scholar 

  10. G.A. Balint andV. Varró,Changes of Endogenous Prostacyclin Level in Different Experimental Gastric Ulcer Models of Rat, 12th International Congress of Gastroenterology, Lisboa, (1984).

  11. J.R. Vane,Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs, Nature (New Biol.)231, 232–235 (1971).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Balint, G.A., Náfrádi, J. & Varró, V. Changes of endogenous prostacyclin-level in different experimental gastroduodenal ulcer models of rat. Agents and Actions 17, 495–497 (1986). https://doi.org/10.1007/BF01965520

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01965520

Keywords

Navigation